Immunocore Overview

  • Abingdon, United Kingdom
  • 201 to 500 Employees
  • 2008
  • Company - Public (IMCR)
  • Biotech & Pharmaceuticals
  • Unknown / Non-Applicable

CompetitorsImmatics Biotechnologies, Adaptimmune
Create Comparison

Immunocore Reviews

Recommend to a Friend
Approve of CEO
Bahija Jallal
Bahija Jallal
6 Ratings
11 Mar 2021Helpful (1)
Immunocore icon

"Great company with a good product"

Former Employee - Senior Scientist in Oxford, England, England
Positive Outlook
Approves of CEO

I worked at Immunocore full-time for more than a year


The products in the pipeline had the potential to change patients lives.


Management seemed to be in transition during my time there and seemed a bit turbulent. However that is hopefully temporary.

Advice to Management

It would bebgreat to see stability in management and the company progressing well.
See All 77 Reviews

Diversity & Inclusion at Immunocore

(12 reviews)

Immunocore Photos

+ Add Photo
Immunocore photo of: [photoCaption]Immunocore photo of: [photoCaption]Immunocore photo of: [photoCaption]Immunocore photo of: [photoCaption]Immunocore photo of: [photoCaption]Immunocore photo of: [photoCaption]Immunocore photo of: [photoCaption]

Immunocore Interviews

Getting an Interview
Applied online83%
Recruitment Agency11%
In Person6%

  1. [employerShortName] icon

    Associate Scientist Interview

    Anonymous Employee in United Kingdom
    No Offer
    Positive Experience
    Easy Interview

    I applied online. The process took 2 months. I interviewed at Immunocore (United Kingdom)


    It was a pretty simple process. Applied and got an email for an interview 2 weeks later, had a second interview 3 weeks after that. Still waiting to hear back. Both interviews were very relaxed and focused on the research that I had been previously doing and why I wanted to apply to this specific area of research. The second interview involved more scientific questions - scenarios about how to set up experiments and the best approaches to common issues in the lab. No typical interview questions i.e - what are you strengths and weaknesses.

    Why did you choose to apply to Immunocore?

    Answer Question

See All 18 interviews

Company Updates

1 December 2017
Immunocore Presents Single Agent IMCgp100 data in Metastatic Uveal Melanoma Showing Durability, Doubling in One-Year Overall Survival Rate Immunocore’s intra-patient dose escalation Phase I IMCgp100 study in metastatic uveal melanoma patients demonstrates a one-year overall survival (OS) rate of 73% (95% confidence interval [46, 88]) and a one-year progression-free-survival (PFS) rate of 62% based on the irRC criteria as of the data cut-off in October 2017. Median OS has not been reached with median follow-up of 12.8 months in this cohort. The overall survival data from this study compare very favourably to studies with other agents, which show one-year OS rates of approximately 25-45%.* For the full press release:
Shared image

Immunocore Awards & Accolades

  • The Sunday Times Tech Track 100The Sunday Times Tech Track 1002017
  • The Sunday Times Tech Track 100The Sunday Times (UK)2016

Popular Careers with Immunocore Job Seekers

Senior Scientist
Learn About the Job

Immunocore FAQ

(15 Questions)

All answers shown come directly from Immunocore Reviews and are not edited or altered.

See questions about:

What is health insurance like at Immunocore?

...Hellish if you're passionate scientists who strive to make real contributions to the healthcare sector....

17 August 2020

Read more

Work at Immunocore? Share Your Experiences

Click to Rate